recordati spa (REC:BrsaItaliana)
Financial Statements for recordati spa (REC)
| Currency in Millions of Euros | As of: | Dec 31 2009 Restated EUR | Dec 31 2010 Restated EUR | Dec 31 2011 Restated EUR | Dec 31 2012 EUR | 4 Year Trend |
| Revenues | 747.5 | 728.1 | 762.0 | 828.3 | ![]() ![]() ![]() ![]() | |
| TOTAL REVENUES | 747.5 | 728.1 | 762.0 | 828.3 | ![]() ![]() ![]() ![]() | |
| Cost of Goods Sold | 235.6 | 240.1 | 260.0 | 293.6 | ![]() ![]() ![]() ![]() | |
| GROSS PROFIT | 511.9 | 488.1 | 502.1 | 534.8 | ![]() ![]() ![]() ![]() | |
| Selling General & Admin Expenses, Total | 268.2 | 261.1 | 278.1 | 296.6 | ![]() ![]() ![]() ![]() | |
| R&D Expenses | 69.4 | 68.8 | 56.0 | 63.4 | ![]() ![]() ![]() ![]() | |
| Other Operating Expenses | 5.7 | -- | -- | -- | ![]() ![]() ![]() ![]() | |
| OTHER OPERATING EXPENSES, TOTAL | 343.3 | 329.9 | 334.0 | 360.0 | ![]() ![]() ![]() ![]() | |
| OPERATING INCOME | 168.6 | 158.1 | 168.0 | 174.8 | ![]() ![]() ![]() ![]() | |
| Interest Expense | -4.8 | -4.1 | -6.8 | -7.2 | ![]() ![]() ![]() ![]() | |
| Interest and Investment Income | -- | 0.0 | 1.7 | 0.4 | ![]() ![]() ![]() ![]() | |
| Other Non-Operating Expenses, Total | -0.3 | 0.9 | 2.1 | 0.7 | ![]() ![]() ![]() ![]() ![]() ![]() ![]() | |
| Merger & Restructuring Charges | -7.1 | -0.5 | -2.7 | -12.2 | ![]() ![]() ![]() ![]() | |
| Gain (Loss) on Sale of Investments | -3.8 | 0.5 | -- | -- | ![]() ![]() ![]() ![]() ![]() ![]() ![]() | |
| Other Unusual Items, Total | 0.0 | -3.9 | -2.4 | 3.9 | ![]() ![]() ![]() ![]() ![]() ![]() ![]() | |
| EBT, INCLUDING UNUSUAL ITEMS | 152.7 | 151.0 | 160.0 | 160.3 | ![]() ![]() ![]() ![]() | |
| Income Tax Expense | 42.1 | 42.4 | 43.6 | 41.8 | ![]() ![]() ![]() ![]() | |
| Minority Interest in Earnings | 0.0 | 0.0 | 0.0 | 0.0 | ![]() ![]() ![]() ![]() | |
| Earnings from Continuing Operations | 110.6 | 108.6 | 116.4 | 118.5 | ![]() ![]() ![]() ![]() | |
| NET INCOME | 110.6 | 108.6 | 116.4 | 118.5 | ![]() ![]() ![]() ![]() | |
| NET INCOME TO COMMON INCLUDING EXTRA ITEMS | 110.6 | 108.6 | 116.4 | 118.5 | ![]() ![]() ![]() ![]() | |
| NET INCOME TO COMMON EXCLUDING EXTRA ITEMS | 110.6 | 108.6 | 116.4 | 118.5 | ![]() ![]() ![]() ![]() | |
| Recently Viewed | |||
| REC:IM | €8.14 EUR | +0.11 | |
| Company | Last | Change |
| Actelion Ltd | SFr.56.85 CHF | -0.80 |
| Faes Farma SA | €2.05 EUR | -0.02 |
| Salix Pharmaceuticals Ltd | $60.39 USD | +0.70 |
| Shire PLC | 2,168 GBp | +34.00 |
| Warner Chilcott PLC | $19.96 USD | -0.04 |
| View Industry Companies | ||
Industry Analysis
REC
Industry Average
| Valuation | REC | Industry Range |
| Price/Earnings | 14.1x |
|
| Price/Sales | 1.9x |
|
| Price/Book | 2.3x |
|
| Price/Cash Flow | 13.8x |
|
| TEV/Sales | 1.6x |
|
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02









